top of page
Search

COVID guidelines update and Antifungal prophylaxis guidelines

francoisbourdeau
Oct 6, 20221 min read

The MUHC ASP committee is happy to announce the update and publication of several guidelines:

  • Pre-exposure prophylaxis to COVID : Recommended Evusheld dose is now increased to 300/300 mg

  • COVID management guidelines (minor changes)

  • COVID outpatient decision tree : inclusion of situation in which to give Evusheld

  • Antifungal prophylaxis guidelines (developed with the help of Transplant and Hematology-oncology team)

We are also proud to publish our Annual report for 2021-2022. It is now available in the section Resources of the website.


Good reading to all and happy thanksgiving!

Francois Bourdeau, ASP co-chair

43 views0 comments

Recent Posts

See All

Linezolid TDM

INESSS approved the TDM of Linezolid in May 2024 It is now available in the MUHC (via HSJ labs) The ASP committee is happy to publish a...

0 comments

MUHC ASP annual report 2022-2023

The ASP chairs are happy to publish the MUHC ASP annual report 2022-2023, now available in the Resources section of the MUHC ASP website....

0 comments

S.aureus bacteremia

The ASP committee is happy to give you an early Christmas gift! We published the guidelines on management and treatment of Staphylococcus...

0 comments

Comments

+1 514-934-1934

1001 Decarie Blvd, Montreal, Quebec H4A 3J1, Canada

bottom of page